NTLA
Intellia Therapeutics
biotech biofarmaceutici utilizzando editing genetico CRISPR
|
Statistiche PeriodoMax: 32.8 Min: 20.02 Δ/gg: 1.33 Vol Med: 1397097.48 Δ Period: -27.68% FTSE correlation: -0.08 |
|||||||||||
Delta a 1w 2024-04-30 (21.98): 7.92 Delta a 2w 2024-04-23 (21.83): 8.66 Delta a 1m 2024-04-09 (25.3): -6.25 Delta a 3m 2024-02-15 (28.47): -16.68 Delta a 6m 2023-11-17 (28.12): -15.65 Delta a 1Y 2023-05-30 (37.55): -36.83 | Registrati per appuntare delle note | |||||||||||